GeneBioTech Co. ,Ltd (KOSDAQ: 086060)

South Korea flag South Korea · Delayed Price · Currency is KRW
3,270.00
-140.00 (-4.11%)
Dec 20, 2024, 3:00 PM KST
-24.04%
Market Cap 28.16B
Revenue (ttm) 80.50B
Net Income (ttm) 2.55B
Shares Out 8.61M
EPS (ttm) 296.00
PE Ratio 11.05
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 55,624
Open 3,375.00
Previous Close 3,410.00
Day's Range 3,270.00 - 3,405.00
52-Week Range 3,050.00 - 4,745.00
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Mar 14, 2025

About GeneBioTech Co. ,Ltd

GeneBioTech Co. ,Ltd, together with its subsidiaries, engages in the manufacture and sale of feed additives and functional food in South Korea. It also manufactures and sells animal drugs. The company was founded in 2000 and is headquartered in Gongju-si, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 2000
Employees 38
Stock Exchange KOSDAQ
Ticker Symbol 086060
Full Company Profile

Financial Performance

In 2023, GeneBioTech Co. ,Ltd's revenue was 79.48 billion, a decrease of -3.97% compared to the previous year's 82.76 billion. Earnings were 2.59 billion, an increase of 70.12%.

Financial Statements

News

There is no news available yet.